in

Danaher’s stock drop looks like a buying opportunity after it reported a solid quarter

Life sciences and medical diagnostics company Danaher (DHR) reported better-than-expected earnings and revenue for the fourth quarter. We view the dip in the stock as unjustified and an opportunity.

Source: Business - cnbc.com

China tells US to fix its own debt problems after Yellen Africa remarks

U.S business activity downturn eases slightly; euro zone back to growth